|
08:30-10:00 |
Keynote Lectures
Advances in Obstetrics, Gynecology and Infertility: Leaders' Views on the Future |
|
|
What does the future hold for our main subdisciplines?
|
| Chairpersons |
Z. Ben-Rafael, Israel
V. Gomel, Canada
G.C. Di Renzo, Italy
|
|
08:30-09:00 |
Fetomaternal Medicine
Intrauterine stem cell transplantation
|
| 09:00-09:30 |
Gynecology
Surgical approach for endometriosis, do we have limits?
F. Nezhat, USA
|
| 09:30-10:00 |
Infertility & ART
The Future of In Vitro Maturation (IVM)
R. Fadini, Italy
|
| 10:00-10:30 |
Coffee break
|
| 10:30-12:30 |
Fostimon, human-type FSH: From basic science to clinical practice
Sponsored by IBSA Institut Biochimique SA |
| Chairpersons |
Z.J. Chen, China
J.L.H. Evers, The Netherlands
V. Gomel, Canada
|
| 10:30-10:35 |
Introduction
|
| 10:35-10:55 |
A critical review of the gonadotrophins used for ovarian stimulation in IVF
S. Daya, Canada
|
| 10:55-11:15 |
Structure-activity relationship of FSH molecular species: Focus on glycosylation
M. Dattilo, Switzerland
|
| 11:15-11:35 |
Effect of FSH stimulation regimens on the pattern of mRNA expression in human cumulus cells
M. Benkhalifa, France
|
| 11:35-11:55 |
Fostimon’s human type FSH: Clinical results
G. D’amato, Italy
|
| 11:55-12:15 |
Human type FSH: The impact on the cost of treatment
S. Gerli, Italy
|
| 12:15-12:30 |
Discussion and conclusions
|
| 12:30-13:30 |
Lunch break
|
| 13:30-15:30 |
Cryopreservation of Gametes and Ovaries |
| Capsule |
The best clinical method for cryopreservation of oocytes and ovarian tissue is yet to be decided
|
| Chairperson |
S.A. Carson, USA
J. Donnez, Beligum
|
| 13:30-14:30 |
Debate
Human Oocyte Cryopreservation: Slow Freezing or Verification Techniques
Human oocyte cryopreservation: The slow-freezing technique
A. Borini, Italy
Human oocyte cryopreservation: Vitrification technique
R. Fadini, Italy
|
|
14:30-15:00
|
Freezing whole human ovaries
P. Patrizio, USA
|
|
15:00-15:30 |
The advantages of zygote vitrification
T. Cordes, Germany
|
| 15:30-16:00 |
Coffee Break
|
| 16:00-18:00 |
Assessment of Ovarian Reserve |
| Capsule |
Decreased ovarian reserve remains a common and frustrating condition despite years of experience. Can we evaluate and provide better treatment?
|
| Chairpersons |
K. Diedrich, Germany
I.E. Messinis, Greece
C.Q. Zhou, China
|
|
16:00-16:25 |
Should we routinely perform tests for ovarian reserve?
A. Maheshwari, UK
|
| 16:25-16:50 |
What does DHEA have to do with treating diminished ovarian reserve?
N. Gleicher, USA
|
| 16:50-17:15 |
Can we rejuvenate defective aged oocytes by ooplasm replacement using germinal vesicle transfer?
K. Kawano, Japan
|
|
17:15-18:00
|
Debate
Proposition: No treatment options for decreased ovarian reserve and low responders are effective. It is only cycle-to-cycle variation that is of importance!
P. Patrizio, USA
Opposition: Better protocols will result in better pregnancy rates!
S. Daya, Canada
Discussion |
|
|
|
|
Saturday, November 14, 2009
|
| 08:30-10:00 |
Clinical Application of the Gamete Freezing |
| Capsule |
The rising efficacy of gamete freezing facilitates diversification of clinical solutions
Organized and endorsed by IVI (Instituto Valenciano de Infertilidad)
|
| Chairpersons |
P. Patrizio USA
A. Requena, Spain
|
| 08:30-09:00 |
What vitrification adds to difficult IVF cases in low and high responders?
I. Ortega, Spain
|
| 09:00-09:30 |
Delaying childbearing: An increasing demand for egg freezing
A. Requena, Spain
|
| 09:30-10:00 |
What are the reproductive options for males suffering from cancer?
N. Garrido, Spain
|
| 10:00-10:30 |
Coffee Break
|
|
10:30-12:30 |
Hot Controversies - Expert Opinion on:
Clinical Aspects of ART |
|
Capsule |
Expert opinions on controversial topics
|
| Chairpersons |
Z. Ben-Rafael, Israel
K. Diedrich, Germany
|
|
Z.J. Chen, China
S.A. Carson, USA
J. Qiao, China
N. Gleicher, USA
S. Daya, Canada
G. Kovacs, Australia |
| Questions |
-
Evidence based supplementation of the corpus luteum in IVF?
-
Minimal monitoring of ovarian stimulation: Is it safe? How minimal?
-
Cheap or expensive FSH preparations?
-
Why did the antagonist not replace the agonist?
-
Do we need the addition of luteinizing hormone (LH) for ovarian stimulation?
-
Risk of ovarian hyperstimulation syndrome (OHSS): Is it a real problem?
-
Intracytoplasmic sperm injection (ICSI) for all patients?
-
Is rescue ICSI effective in conventional IVF or ICSI?
-
Assisted zona hatching: What is the evidence?
-
Embryo transfer (ET); Do we really need US?
-
Is the ET technique important?
-
Single embryo transfer (SET) for all?
-
Is there a risk of cancer after ovarian stimulation? |
| 12:30-13:30 |
Lunch break
|
|
|
Infertility Practice |
| Capsule |
Many practical issues are still unsettled
|
| Chairpersons |
S. Daya, Canada
G. Kovacs, Australia
|
| 13:30-14:00 |
Ovarian cortex cryopreservation and transplantation: Advantages and perils!
J. Donnez, Belgium
|
| 14:00-14:30 |
Control of LH secretion in PCOS
K. Ntafopoulos, Greece
|
| 14:30-15:00 |
The role of LH in ovarian stimulation
I.E. Messinis, Greece
|
|
15:00-15:30 |
Metabolic Characteristics in PCOS in China
Z.J. Chen, China
|
| 15:30-16:00 |
Coffee Break
|
|
16:00-18:00 |
Polycystic Ovarian Syndrome (PCOS) in the Asia-Pacific Region |
| Capsule |
Disagreement regarding basic criteria for definition of PCOS, are also region dependent?
Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG)
|
| Chairpersons |
P.C. Ho, Hong Kong
N. Gleicher, USA
Z.J. Chen, China
|
| 16:00-16:45 |
Views: Do we need a different set of criteria for defining PCOS in this region?
Views from East Asia
M. Hsu, Taiwan
Views from South Asia
D. Shah, India
Discussion |
|
|
| 16:45-17:30 |
Views: Do we need different treatment for Asian PCOS?
J.Tank, India
J. Qiao, China
Discussion |
|
17:30-18:00 |
Can we prevent OHSS syndrome?
H. Sallam, Egypt
|
|
18:30-20:00 |
"Voices"
Special Entertainment Lecture by Dr. C.O. (Skip) Granai, USA
|
|
Sunday, November 15, 2009
|
| 08:30-10:00 |
In-Vitro Maturation (IVM) |
| Capsule |
Despite many improvements, IVM is still experimental: Risk benefits and pitfalls should be clarified
|
| Chairpersons |
A. Borini, Italy
E. Ng, Hong Kong
|
| 08:30-09:30 |
Debate
Will IVM Ever Replace Standard IVF?
Yes: IVM should be an integral part of IVF Service
M. Leong, Hong Kong
No: IVM does not offer any advantage over current IVF practice
K.R. Held, Germany |
|
09:30-10:00 |
How should selection of women be improved, and their IVM cycles optimized?
R. Fadini, Italy
|
| 10:00-10:30 |
Coffee break
|
| 10:30-12:30 |
Increasing Success Rate in ART |
| Capsule |
Can better laboratory techniques bring about a breakthrough in success rate?
Organized and endorsed by The Asia and Oceana Federation of Obstetrics and Gynecology (AOFOG)
|
| Chairpersons |
H.N. Sallam, Egypt
M. Leong, Hong Kong
|
| 10:30-11:30 |
Debate
The end of the Preimplantation Genetic Screening (PGS) Era?
Pros: PGS is associated with lower success rate and should not be offered as a screening tool!
N. Gleicher, USA
Cons: PGS has a role provided it correctly performed!
K.R. Held, Germany |
|
11:30-12:00 |
What can be achieved by acupuncture in assisted reproduction?
E. Ng, Hong Kong
|
| 12:00-12:30 |
Does OHSS impair endometrial receptivity?
P.C. Ho, Hong Kong
|
WebStudio.co.il
